Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01950377 · ClinicalTrials.gov registry record

Imaging and Genetic Investigation of Learning and Decision Making

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
78
Enrollment target

NCT01950377 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 78 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01950377 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
78 participants
Enrollment target

Study Summary

Background: \- Previous research has shown that dopamine, a brain chemical, is involved in decision making. Different genes influence how much dopamine people have in their brains and how that affects their behavior. Researchers will study if genes associated with dopamine affect decision making and impulsiveness. All participants will take tests; some will have brain images taken. Researchers will study the test responses and images; they will look for how differences in these genes affect different types of decision making. Objectives: \- To see if genes involved in a brain chemical, dopamine, are related to impulsiveness on behavioral tests. Eligibility: \- Healthy adults ages 18 to 55. Design: * Participants will be screened with a medical history and physical exam. * All participants in this study will have at least 1 outpatient visit to the NIH Clinical Center. Each visit will last 2 4 hours. At the first visit: * A blood sample will be taken only from participants that have not been previously enrolled in 95-M-0150 * Participants will be given tests of their memory, attention, concentration, and thinking. * Some participants will have a second visit. It will be scheduled as soon as possible after the first. At the second visit: * Participants will have an MRI (magnetic resonance imaging). They will have to lie in a scanner for up to 2 hours. The MRI uses magnets, radio waves, and computers to produce detailed pictures of the brain. * Participants will repeat the tests from the first visit. Some will be done during the MRI.

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2014-02-11
Est. Completion 2020-03-05

What the Registry Record Tells You About NCT01950377

The ClinicalTrials.gov registry entry for NCT01950377 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01950377 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01950377 about?

NCT01950377 is a clinical study titled "Imaging and Genetic Investigation of Learning and Decision Making". Background: \- Previous research has shown that dopamine, a brain chemical, is involved in decision making. Different genes influence how much dopamine people have in their brains and how that affects their behavior. Researchers will study if genes associated with dopamine affect decision making an...

What is the current status of trial NCT01950377?

This trial is currently completed. The enrollment target is 78 participants. The study started on 2014-02-11. Estimated completion is 2020-03-05.

Who is sponsoring clinical trial NCT01950377?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.